RehabNytte - A Study of Rehabilitation Processes in Specialized Care in Norway
Launched by DIAKONHJEMMET HOSPITAL · Dec 4, 2018
Trial Information
Current as of May 18, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The RehabNytte trial is a study focused on understanding how rehabilitation affects people's health and quality of life during the first year after they receive care. Researchers want to learn about how involved patients are in their own rehabilitation process and what factors influence their ability to work and participate in daily activities after treatment. They will also be testing new ways to measure the outcomes of rehabilitation, which is important for improving care in Norway.
To participate in this study, individuals must be over 18 years old and currently involved in a rehabilitation program at one of the participating centers. They also need to have access to the internet and a secure personal login. However, people with severe cognitive impairments or mental health issues that prevent them from giving consent, as well as those who do not understand written Norwegian, will not be eligible. Participants can expect to share their experiences and provide feedback to help improve rehabilitation services for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients that participates in inpatient or outpatient rehabilitation programs at one of the participating centers.
- • Age over 18 years
- • Access to internet at home
- • Access to personal secure login with BANK ID.
- Exclusion Criteria:
- • Severely reduced cognitive function
- • severe mental illness with inadequate consent competence ability to participate
- • Insufficient understanding of Norwegian written language.
About Diakonhjemmet Hospital
Diakonhjemmet Hospital is a leading healthcare institution in Norway, dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the hospital fosters a research environment that prioritizes patient safety and ethical standards. Committed to translating scientific findings into clinical practice, Diakonhjemmet Hospital engages in a diverse range of studies across various medical fields, aiming to enhance treatment outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alta, , Norway
Bergen, , Norway
Eiken, , Norway
Evje, , Norway
Flekke, , Norway
Hagavik, , Norway
Hernes, , Norway
Hønefoss, , Norway
Jaren, , Norway
Klæbu, , Norway
Lier, , Norway
Lillehammer, , Norway
Lillehammer, , Norway
Lørenskog, , Norway
Son, , Norway
Valldal, , Norway
Vikersund, , Norway
Alta, , Norway
Hønefoss, , Norway
Patients applied
Trial Officials
Tore K Kvien, Professor
Study Director
Dep.Rheumatology, Diakonhjemmet hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials